Most notably, the AT-rich phosphorothioate aptamer (AT-sDNA) increased the sensitivity of Miapaca-2 and AsPC-1 pancreatic cancer cell lines to gemcitabine treatment, presumably by acting as a decoy to bind to excess HMGA1 [143]. Here, HMGA1 is linked to familial pancreatic carcinoma.